Abstract:Background: Non-alcoholic fatty liver disease (NAFLD) is a risk factor for hepatocellular carcinoma (HCC). However, its carcinogenic mechanism is still unclear, looking for both diseases' transcriptome levels, the same changes as we are looking for NAFLD may provide a potential mechanism of action of HCC. Thus, our study aimed to discover the coexisting pathogenic genes of NAFLD and HCC. Methods: We performed a variance analysis with public data for both diseases. At the same time, weighted gene correlation network analysis (WGCNA) was used to find highly correlated gene modules in both diseases. The darkturquoise gene module was found to be highly correlated with both diseases. Based on the diagnosis related module genes and the differential genes of the two diseases, we constructed diagnostic and prognostic models by logistic regression, univariate Cox regression, and LASSO regression. Public datasets verified the results. Meanwhile, we built a competing endogenous RNA (ceRNA) network based on the model genes and explored the related pathways and immune correlation involved in the two diseases by using Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and gene set enrichment analyses. Immunohistochemistry was used to verify the different expression of ABCC5 and TUBG1 among the normal liver, NAFLD, and HCC tissues. Sodium palmitate/sodium oleate was used to establish high-fat cell models, and Real Time Quantitative Polymerase Chain Reaction (RT-qPCR) was used to verify the messenger RNA (mRNA) expression of ABCC5 in lipidization cells. Results: A total of 26 upregulated genes and 87 downregulated genes were found using limma package identification analysis. According to WGCNA, the darkturquoise gene module was highly correlated with the prognosis of both diseases. The coexisting genes acquired by the two groups were only three central genes, that is, ABCC5, DHODH and TUBG1. The results indicated that the diagnostic and prognostic models constructed by ABCC5 and TUBG1 genes had high accuracy in both diseases. The results of immunohistochemistry showed that ABCC5 and TUBG1 were significantly overexpressed in NAFLD and HCC tissues compared with normal liver tissues. The Oil Red O staining and triglyceride identified the successful construction of HepG2 and LO2 high-fat models using PA/OA. The results of RT-qPCR showed that the lipidization of LO2 and HepG2 increased the mRNA expression of ABCC5. Conclusions: The gene model constructed by ABCC5 and TUBG1 has high sensibility and veracity in the diagnosis of NAFLD as well as the diagnosis and prognosis of HCC. ABCC5 and TUBG1 may play an important role in the development of NAFLD to HCC. In addition, lipidization could upregulate the mRNA expression of ABCC5 in HCC.

Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease

Identification of Genes and Key Pathways Underlying the Pathophysiological Association Between Nonalcoholic Fatty Liver Disease and Atrial Fibrillation

Identification of Hub Genes Associated with Non-alcoholic Steatohepatitis Using Integrated Bioinformatics Analysis

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysis

Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease

Integrated Analysis of a Noncoding RNA-Associated Competing Endogenous RNA Network in Non-Alcoholic Fatty Liver Disease

Identification of Key Genes and Pathways in Mild and Severe Nonalcoholic Fatty Liver Disease by Integrative Analysis.

Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease.

Identification of Key Pathways and Genes in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis

Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis

Functional Investigation and Two-Sample Mendelian Randomization Study of Non-Alcoholic Fatty Liver Disease Hub Genes Obtained by WGCNA

Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma

A Comprehensive Bioinformatics Analysis on Multiple Gene Expression Omnibus Datasets of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease

Identification of key modules and driving genes in nonalcoholic fatty liver disease by weighted gene co-expression network analysis

A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma.

Bioinformatics Analysis Reveals Novel Core Genes Associated with Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Identification and validation of cuproptosis-related genes for diagnosis and therapy in nonalcoholic fatty liver disease

Identification of autophagy-related signatures in nonalcoholic fatty liver disease and correlation with non-parenchymal cells of the liver

Combined with multiplex and network analysis to reveal the key genes and mechanisms of nonalcoholic fatty liver disease